Literature DB >> 25066919

Clinical features and types of articular involvement in patients with psoriatic arthritis.

Salim Dönmez1, Ömer Nuri Pamuk, Mustafa Akker, Recep Ak.   

Abstract

Psoriatic arthritis (PsA) is a psoriasis-associated inflammatory arthritis which causes joint destruction. There are some epidemiologic data about PsA; however, there are no sufficient data from Turkey. Herein, we evaluated the frequency of PsA in the Thrace region of Turkey according to hospital-based data. In addition, we evaluated clinical features and types of joint involvement in PsA patients. We included 172 PsA patients fulfilling CASPAR criteria admitted to the Division of Rheumatology, Trakya University Medical Faculty, between 2003 and 2012. Data from Turkish Statistical Institution was used to calculate the incidence and prevalence of PsA. Patients' demographic features, durations of psoriasis and PsA, number of tender and swollen joints, treatment modalities, laboratory data, and X-ray film findings were recorded from hospital files. The annual incidence of PsA was 2.8/100,000. The mean annual incidence was 3.47/100,000 in females and 2.15/100,000 in males. The overall prevalence of PsA in our region was 27.9/100,000 (95 % confidence interval (CI) 23.7-32.1) in individuals >16 years. The prevalence of PsA was higher in females than in males (34.7/100,000 vs. 21.5/100,000). Polyarthritis was present in 67 (38.9 %), oligoarthritis in 47 (27.3 %), spondyloarthritis in 39 (22.6 %), and distal interphalangeal (DIP) arthritis in 19 (11.0 %) patients. The duration of psoriasis was significantly longer in polyarticular PsA patients than in DIP and oligoarticular groups (p values = 0.016 and 0.018, respectively). The number of swollen joints correlated with age (r = 0.21, p = 0.006), duration of psoriasis (r = 0.20, p = 0.01), number of tender joints (r = 0.92, p ≤ 0.001), ESR (r = 0.24, p = 0.001), and CRP (r = 0.17, p = 0.026). The frequency of PsA in Thrace region is similar to that in low-frequency regions. The most frequent type of involvement was polyarticular, and it correlated with the duration of psoriasis and erosive disease.

Entities:  

Mesh:

Year:  2014        PMID: 25066919     DOI: 10.1007/s10067-014-2746-4

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  27 in total

Review 1.  Epidemiology of psoriatic arthritis.

Authors:  William J Taylor
Journal:  Curr Opin Rheumatol       Date:  2002-03       Impact factor: 5.006

Review 2.  Psoriasis and its comorbidities.

Authors:  Neh Onumah; Leon H Kircik
Journal:  J Drugs Dermatol       Date:  2012-05       Impact factor: 2.114

3.  Incidence and prevalence of psoriatic arthritis: a systematic review.

Authors:  Yannis Alamanos; Paraskevi V Voulgari; Alexandros A Drosos
Journal:  J Rheumatol       Date:  2008-05-01       Impact factor: 4.666

4.  Incidence of psoriatic arthritis in Finland.

Authors:  O Kaipiainen-Seppänen
Journal:  Br J Rheumatol       Date:  1996-12

5.  Analysis of clinical, radiological and laboratory variables in psoriatic arthritis with 25 Japanese patients.

Authors:  Hideki Maejima; Tomonori Taniguchi; Akira Watarai; Ryouichi Aki; Kensei Katsuoka
Journal:  J Dermatol       Date:  2010-07       Impact factor: 4.005

6.  Rheumatic manifestations of psoriasis.

Authors:  H A Sadek; A M Abdel-Nasser; T A El-Amawy; S Z Hassan
Journal:  Clin Rheumatol       Date:  2006-05-03       Impact factor: 2.980

7.  Epidemiology of spondyloarthritis in North America.

Authors:  John D Reveille
Journal:  Am J Med Sci       Date:  2011-04       Impact factor: 2.378

8.  Psoriatic arthritis (PSA)--an analysis of 220 patients.

Authors:  D D Gladman; R Shuckett; M L Russell; J C Thorne; R K Schachter
Journal:  Q J Med       Date:  1987-02

9.  Epidemiology of psoriatic arthritis in northwest Greece, 1982-2001.

Authors:  Yannis Alamanos; Nikolaos G Papadopoulos; Paraskevi V Voulgari; Christos Siozos; Dimitrios N Psychos; Maria Tympanidou; Alexandros A Drosos
Journal:  J Rheumatol       Date:  2003-12       Impact factor: 4.666

10.  Epidemiological and clinical characteristics of psoriatic arthritis in northern Norway.

Authors:  J C Nossent; J T Gran
Journal:  Scand J Rheumatol       Date:  2009       Impact factor: 3.641

View more
  9 in total

Review 1.  Sex- and gender-related differences in psoriatic arthritis.

Authors:  Sanjana Tarannum; Ying-Ying Leung; Sindhu R Johnson; Jessica Widdifield; Vibeke Strand; Paula Rochon; Lihi Eder
Journal:  Nat Rev Rheumatol       Date:  2022-08-04       Impact factor: 32.286

Review 2.  Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021.

Authors:  Laura C Coates; Enrique R Soriano; Nadia Corp; Heidi Bertheussen; Kristina Callis Duffin; Cristiano B Campanholo; Jeffrey Chau; Lihi Eder; Daniel G Fernández-Ávila; Oliver FitzGerald; Amit Garg; Dafna D Gladman; Niti Goel; Philip S Helliwell; M Elaine Husni; Deepak R Jadon; Arnon Katz; Dhruvkumar Laheru; John Latella; Ying-Ying Leung; Christine Lindsay; Ennio Lubrano; Luis Daniel Mazzuoccolo; Philip J Mease; Denis O'Sullivan; Alexis Ogdie; Wendy Olsder; Penelope Esther Palominos; Lori Schick; Ingrid Steinkoenig; Maarten de Wit; D A van der Windt; Arthur Kavanaugh
Journal:  Nat Rev Rheumatol       Date:  2022-06-27       Impact factor: 32.286

Review 3.  Differentiating Psoriatic Arthritis from Osteoarthritis and Rheumatoid Arthritis: A Narrative Review and Guide for Advanced Practice Providers.

Authors:  William Saalfeld; Amanda M Mixon; Jonna Zelie; Eileen J Lydon
Journal:  Rheumatol Ther       Date:  2021-09-14

4.  The Epidemiology of Psoriatic Arthritis Over Five Decades: A Population-Based Study.

Authors:  Paras Karmacharya; Cynthia S Crowson; Delamo Bekele; Sara J Achenbach; John M Davis; Alexis Ogdie; Alí Duarte-García; Floranne C Ernste; Hilal Maradit-Kremers; Megha M Tollefson; Kerry Wright
Journal:  Arthritis Rheumatol       Date:  2021-08-14       Impact factor: 15.483

5.  Higher prevalence of psoriatic arthritis in the adult population in Spain? A population-based cross-sectional study.

Authors:  Antonio Romero Pérez; Rubén Queiro; Daniel Seoane-Mato; Eduard Graell; Eugenio Chamizo; Lara Chaves Chaparro; Sara Rojas Herrera; Jordi Pons Dolset; Miguel A Polo Ostáriz; Susana Ruiz-Alejos Garrido; Cristina Macía-Villa; Ana Cruz-Valenciano; María L González Gómez; Carlos Sánchez-Piedra; Federico Díaz-González; Sagrario Bustabad-Reyes
Journal:  PLoS One       Date:  2020-06-17       Impact factor: 3.240

6.  The impact of different rheumatic diseases on health-related quality of life: a comparison with a selected sample of healthy individuals using SF-36 questionnaire, EQ-5D and SF-6D utility values.

Authors:  Fausto Salaffi; Marco Di Carlo; Marina Carotti; Sonia Farah; Alessandro Ciapetti; Marwin Gutierrez
Journal:  Acta Biomed       Date:  2019-01-15

7.  Clinical Characteristics of Patients With Psoriatic Spondylitis Versus Those With Ankylosing Spondylitis: Features at Baseline Before Biologic Therapy.

Authors:  Hyoun-Ah Kim; Eunyoung Lee; So Young Park; Shin-Seok Lee; Kichul Shin
Journal:  J Korean Med Sci       Date:  2022-08-22       Impact factor: 5.354

8.  Reliability and Validity of the Turkish Adaptation of VITACORA-19 in Patients with Psoriatic Arthritis.

Authors:  Berna Tander; Yasemin Ulus; Yüksel Terzi; Yeliz Zahiroğlu; Hakan Kesmen; Bayram Farisoğullari; Yeşim Akyol; Ayhan Bilgici; Ömer Kuru
Journal:  Arch Rheumatol       Date:  2016-07-27       Impact factor: 1.472

9.  Distinguishing rheumatoid arthritis from psoriatic arthritis.

Authors:  Joseph F Merola; Luis R Espinoza; Roy Fleischmann
Journal:  RMD Open       Date:  2018-08-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.